Clinical Trial Update: A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics [Phase 1]

View source ↗

Summary

Phase 1 study comparing insulin peglispro and glargine in type 2 diabetes completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glargine (insulin glargine)
• Insulin Peglispro (insulin peglispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2018-11-01